Psychedelic drug MDMA faces questions as FDA considers approval for PTSD

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD


WASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the
medical mainstream.

https://www.pbs.org/newshour/health/psychedelic-drug-mdma-faces-questions-as-fda-considers-approval-for-ptsd